The FLAURA2 trial was extensively discussed at WCLC 2026 late-breaking abstracts, with updated data presented…
Browsing: biotech analysis
Squamous NSCLC was discussed at WCLC 2026, with immunotherapy combinations and novel therapeutic approaches featured…
The COPERNICUS trial was featured at WCLC 2026 late-breaking abstracts with data in WCLC 2026…
Large-cell neuroendocrine carcinoma was discussed at WCLC 2026 abstracts in sessions exploring the spectrum of…
The AMIGO-1 (LACOG 0821) trial was presented at WCLC 2026 late-breaking abstracts among the WCLC…
KRAS G12D-mutated NSCLC was a highlight at WCLC 2026 highlights, with rilvegostomig featured in WCLC…
The ARROS-1 trial was featured at WCLC 2026 late-breaking abstracts in WCLC 2026 oral presentations,…
The TAISHAN-302 trial was presented at WCLC 2026 oral presentations among the WCLC 2026 abstracts,…
EGFR-mutated NSCLC was a central theme at WCLC 2026 oral presentations, with osimertinib, amivantamab, lazertinib,…
Selpercatinib, a selective RET TKI, was discussed at WCLC 2026 oral presentations in RET fusion-positive…